Vang DP
No ORCID on file
· 1 paper in corpus
2017
ObjectiveOspemifene, an estrogen receptor agonist/antagonist approved for the treatment of dyspareunia and vaginal dryness in postmenopausal women, has potential new indications as an immune modulator. The overall objective of the present s…